Answers are grounded in this paper and cite their sources.
Two mutual prodrugs, in which two different anti-cancer drugs are attached to the same molecule via labile linkages, are synthesized and examined kinetically. One of the mutual prodrugs loses a drug component under physiological conditions within an hour, but the other mutual prodrug (having a longer spacer between the two drugs) is stable to chemical degradation even at higher pH values. Thus, enzymatic hydrolysis alone will release the two anti-cancer drugs. The potential value of anti-cancer mutual prodrugs is discussed.
No takes yet. Share an insight, caveat, or question.
Menger et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: